These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 6545274)

  • 1. Dosimetry and dose-response relationships.
    Neumann HG
    IARC Sci Publ; 1984; (59):115-26. PubMed ID: 6545274
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose-dependent binding of ortho-phenylphenol to protein but not DNA in the urinary bladder of male F344 rats.
    Kwok ES; Buchholz BA; Vogel JS; Turteltaub KW; Eastmond DA
    Toxicol Appl Pharmacol; 1999 Aug; 159(1):18-24. PubMed ID: 10448121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular dosimetry techniques in human risk assessment: an industrial perspective.
    Wright AS
    Dev Toxicol Environ Sci; 1983; 11():311-8. PubMed ID: 6329628
    [No Abstract]   [Full Text] [Related]  

  • 4. The dose-dependence of DNA interactions of aminostilbene derivatives and other chemical carcinogens.
    Neuman HG
    Dev Toxicol Environ Sci; 1983; 11():135-44. PubMed ID: 6677450
    [No Abstract]   [Full Text] [Related]  

  • 5. Alterations in DNA, RNA and protein contents in liver and kidney of mice treated with ochratoxin and their amelioration by Emblica officinalis aqueous extract.
    Verma R; Chakraborty D
    Acta Pol Pharm; 2008; 65(1):3-9. PubMed ID: 18536167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a molecular equivalent dose: use of the medaka model in comparative risk assessment.
    Hobbie KR; Deangelo AB; King LC; Winn RN; Law JM
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Mar; 149(2):141-51. PubMed ID: 18722551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dosimetry and repair of N(2),3-ethenoguanine in rats exposed to vinyl chloride.
    Morinello EJ; Ham AJ; Ranasinghe A; Nakamura J; Upton PB; Swenberg JA
    Cancer Res; 2002 Sep; 62(18):5189-95. PubMed ID: 12234983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure.
    Cupid BC; Lightfoot TJ; Russell D; Gant SJ; Turner PC; Dingley KH; Curtis KD; Leveson SH; Turteltaub KW; Garner RC
    Food Chem Toxicol; 2004 Apr; 42(4):559-69. PubMed ID: 15019179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the isolated perfused rat liver to study carcinogen-DNA adduct formation from aflatoxin B1 and sterigmatocystin.
    Essigmann JM; Donahue PR; Story DL; Wogan GN; Brunengraber H
    Cancer Res; 1980 Nov; 40(11):4085-91. PubMed ID: 6781740
    [No Abstract]   [Full Text] [Related]  

  • 10. The binding of metabolites of aminoazo dyes to rat liver DNA in vivo.
    Dingman CW; Sporn MB
    Cancer Res; 1967 May; 27(5):938-44. PubMed ID: 6025257
    [No Abstract]   [Full Text] [Related]  

  • 11. Absorption and disposition of MeIQx in man: lessons for human dosimetry.
    Boobis AR; Gooderham NJ; Murray BP; Murray S; Lynch A; Sesardic D; Davies DS
    Prog Clin Biol Res; 1991; 372():89-98. PubMed ID: 1956951
    [No Abstract]   [Full Text] [Related]  

  • 12. Relationships of bioassay data on chemicals to their toxic and carcinogenic risk for humans.
    Pitot HC
    J Environ Pathol Toxicol; 1980 Mar; 3(4 Spec No):431-50. PubMed ID: 6993617
    [No Abstract]   [Full Text] [Related]  

  • 13. Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats.
    Dingley KH; Freeman SP; Nelson DO; Garner RC; Turteltaub KW
    Drug Metab Dispos; 1998 Aug; 26(8):825-8. PubMed ID: 9698300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,3-butadiene: cancer, mutations, and adducts. Part IV: Molecular dosimetry of 1,3-butadiene.
    Blair IA; Oe T; Kambouris S; Chaudhary AK
    Res Rep Health Eff Inst; 2000 Mar; (92):151-90; discussion 211-9. PubMed ID: 10925841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embryonic turkey liver: activities of biotransformation enzymes and activation of DNA-reactive carcinogens.
    Perrone CE; Ahr HJ; Duan JD; Jeffrey AM; Schmidt U; Williams GM; Enzmann HH
    Arch Toxicol; 2004 Oct; 78(10):589-98. PubMed ID: 15167984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular dosimetry of N-7 guanine adduct formation in mice and rats exposed to 1,3-butadiene.
    Koc H; Tretyakova NY; Walker VE; Henderson RF; Swenberg JA
    Chem Res Toxicol; 1999 Jul; 12(7):566-74. PubMed ID: 10409395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response relationship in the primary lesion of strong electrophilic carcinogens.
    Neumann HG
    Arch Toxicol Suppl; 1980; 3():69-77. PubMed ID: 6930951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA binding and stimulation of cell division in the carcinogenicity of styrene 7,8-oxide.
    Lutz WK; Cantoreggi S; Velic I
    IARC Sci Publ; 1993; (127):245-52. PubMed ID: 8070870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats.
    Hard GC; Iatropoulos MJ; Jordan K; Radi L; Kaltenberg OP; Imondi AR; Williams GM
    Cancer Res; 1993 Oct; 53(19):4534-41. PubMed ID: 8402624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macromolecule adducts, target dose and risk assessment.
    Ehrenberg L; Osterman-Golkar S; Törnqvist M
    Prog Clin Biol Res; 1986; 209B():253-60. PubMed ID: 3749083
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.